Florence Geiguer
Pierre-la-treiche, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon-19-deleted advanced NSCLC mutation.
Journal: FEBS open bio
Published: August 28, 2024
Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling.
Journal: Biomolecules
Published: July 05, 2023
Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays.
Journal: Cancers
Published: December 30, 2022
Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept.
Journal: Cancers
Published: June 10, 2022
Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAMTM EGFR V2 and NGS Technologies.
Journal: Molecular diagnosis & therapy
Published: February 03, 2021
Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools.
Journal: Scientific reports
Published: December 03, 2020
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
Journal: Journal of visualized experiments : JoVE
Published: September 03, 2019
Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
Journal: Cancer medicine
Published: February 21, 2019
Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy).
Journal: Oncotarget
Published: November 03, 2017
Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Journal: British journal of cancer
Published: March 13, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026